Mikuteit M, Zschäbitz S, Erlmeier M, Autenrieth M, Weichert W, Hartmann A, Steffens S, Erlmeier F (2022)
Publication Type: Journal article
Publication year: 2022
Book Volume: 100
Pages Range: 536-541
Journal Issue: 10
DOI: 10.1159/000525601
BACKGROUND: Overexpression of tumor-associated growth arrest-specific protein 6 (Gas6) is found in many tumor entities. The prognostic value of Gas6 in renal cell carcinoma (RCC), especially in non-clear cell RCC, is still unclear. AIM: The aim of the study was to evaluate the prognostic impact of Gas6 expression in a large cohort of patients with chromophobe RCC (chRCC). MATERIAL AND METHODS: Patients who underwent renal surgery due to chRCC were retrospectively evaluated. Tumor specimens were analyzed for Gas6 expression by immunohistochemistry. RESULTS: Eighty-one chRCC patients were eligible for analysis; of these, 24 (29.6%) patients were positive for Gas6. No significant associations were found for Gas6 expression and clinical attributes in patients with chRCC. The Kaplan-Meier analysis revealed no differences in 5-year overall survival for Gas6- compared to Gas6+ (89.6% vs. 100.0%; p = 0.288) tumors. CONCLUSION: In chRCC, Gas6 expression is not associated with survival and other parameters of aggressiveness. Due to the rare incidence of chRCC, further studies with larger cohorts are warranted.
APA:
Mikuteit, M., Zschäbitz, S., Erlmeier, M., Autenrieth, M., Weichert, W., Hartmann, A.,... Erlmeier, F. (2022). Growth Arrest-Specific 6 in Chromophobe Renal Cell Carcinoma. Oncology, 100(10), 536-541. https://dx.doi.org/10.1159/000525601
MLA:
Mikuteit, Marie, et al. "Growth Arrest-Specific 6 in Chromophobe Renal Cell Carcinoma." Oncology 100.10 (2022): 536-541.
BibTeX: Download